STXS News - Candlesense

Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025

ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its techn...

Conference

1 day ago

Stereotaxis Reports 2025 Second Quarter Financial Results

ST. LOUIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial ...

Are there any risks or uncertainties highlighted in the MD&A that could pose challenges to the company's future performance? What is the expected impact of this earnings release on the stock's price momentum and trading volume in the short term? How might macroeconomic factors, such as healthcare spending trends or reimbursement policy changes, affect Stereotaxis's near‑term prospects?

Earnings

22 days ago